Hanspeter Amstutz

Title: The Innovations of Hanspeter Amstutz

Introduction

Hanspeter Amstutz is a notable inventor based in Bolligen, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the development of polypeptides with specific applications in pharmaceuticals and diagnostics. With a total of 3 patents, his work has the potential to impact medical treatments and diagnostic processes.

Latest Patents

Amstutz's latest patents focus on polypeptides capable of forming antigen binding structures with specificity for the Rhesus D antigens. These patents detail the DNA encoding these polypeptides and the processes for their preparation and use. The polypeptides, which are Fab fragments, may be utilized directly as active ingredients in pharmaceutical and diagnostic compositions. Furthermore, the Fab fragments and their DNA sequences can be employed in the preparation of complete recombinant Anti-Rhesus D antibodies, making them useful in various medical applications.

Career Highlights

Throughout his career, Hanspeter Amstutz has worked with prominent companies in the biotechnology sector, including ZLB Behring AG and ZLB Bioplasma AG. His experience in these organizations has contributed to his expertise in developing innovative solutions in the field.

Collaborations

Amstutz has collaborated with notable colleagues such as Andreas Morell and Martin Imboden. These partnerships have likely enhanced his research and development efforts, leading to advancements in his patented technologies.

Conclusion

Hanspeter Amstutz's contributions to biotechnology through his innovative patents demonstrate his commitment to advancing medical science. His work on polypeptides for Rhesus D antigens showcases the potential for significant improvements in pharmaceutical and diagnostic applications.